Subscribe Now Subscribe Today
Science Alert
 
FOLLOW US:     Facebook     Twitter
Blue
   
Curve Top
Trends in Medical Research
  Year: 2008 | Volume: 3 | Issue: 2 | Page No.: 82-89
DOI: 10.3923/tmr.2008.82.89
Preliminary Clinical Assessment of a Gentamicin-Loaded Monoolein Gel Intended to Treat Chronic Osteomyelitis
Moustapha Ouedraogo, Christophe S. Da, Innocent S. Nacoulma, Hamado Kafando, Rasmane Semde, Issa T. Some, Rasmata Ouedraogo, Innocent P. Guissou, Brigitte Evrard, Viviane Henschel, Jacques Dubois and Karim Amighi

Abstract:
The aim of this current study was to perform a preliminary clinical assessment of efficacy and safety of a biodegradable gentamicin-loaded monoolein gel. An open single dose, one treatment study including 19 patients with chronic osteomyelitis caused by a microorganism sensitive to gentamicin was conducted. After surgical curettage of the infected bone, the dead space was filled in with the gentamicin-loaded monoolein gel. To prevent post-operative septicaemia, a systemic antibiotherapy was prescribed for 3 days following the operation. Clinical, biological and radiological follow-up was performed to assess the efficacy and the safety of the treatment. After a follow-up period ranging from 2 to 12 months, all 19 patients included in the study felt well. Eighteen patients recovered from chronic osteomyelitis without adverse events. The wound of one patient whose bone was exposed did not scar over after 10 months. However, it was no longer infected. In conclusion, gentamicin-loaded monoolein gel was efficacious in treating chronic osteomyelitis without side-effects.
PDF Fulltext XML References Citation Report Citation
How to cite this article:

Moustapha Ouedraogo, Christophe S. Da, Innocent S. Nacoulma, Hamado Kafando, Rasmane Semde, Issa T. Some, Rasmata Ouedraogo, Innocent P. Guissou, Brigitte Evrard, Viviane Henschel, Jacques Dubois and Karim Amighi, 2008. Preliminary Clinical Assessment of a Gentamicin-Loaded Monoolein Gel Intended to Treat Chronic Osteomyelitis. Trends in Medical Research, 3: 82-89.

DOI: 10.3923/tmr.2008.82.89

URL: https://scialert.net/abstract/?doi=tmr.2008.82.89

 
COMMENT ON THIS PAPER
 
 
 

 

 
 
 
 
 
 
 
 
 

 
 
 
 
 

       

       

Curve Bottom